Drospirenone And Ethinyl Estradiol
Product Images NDC 75834-115

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 75834-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

This text provides a list of different hazard ratios, rate ratios, and odds ratios obtained from various studies such as Ingenix, EURAS, LSS, FDA-funded study, Danish, Danish re-analysis, MEGA study, German case-control, PharMetrics, and GPRD study. The text also mentions that these ratios were obtained from prospective cohort studies.*

FDA Label Image

Image-02 (Image 02)

This is a figure showing the likelihood of developing venous thromboembolism based on different factors including pregnancy, postpartum, and use of contraceptives. The data in the figure presents the number of women out of 10,000 women who are expected to develop blood clots in a year. The figure also shows that the likelihood of developing a blood clot varies depending on the risk factor.*

FDA Label Image

Image-03 (Image 03)

Drospirenone Ethinyl estradiol is a combination medication used as birth control to prevent pregnancy.*

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Image-05 (Image 05)

This text is a warning to women who smoke not to use Yasmin if they are over 35 years old, as smoking can increase the risk of serious cardiovascular side effects from birth control pills, including heart attack, blood clots or stroke. The risk increases with age and the number of cigarettes smoked.*

FDA Label Image

Image-06 (Image 06)

The text appears to contain typographical errors and inconsistent formatting. Therefore, it is difficult to infer a meaningful description from this text. It is not available.*

FDA Label Image

Image-07 (Image 07)

FDA Label Image

Image-08 (Image 08)

This is a medical chart displaying the range of blood clot occurrences in non-pregnant and postpartum women who are both non-users and users of contraceptives. The chart contains numerical values for the number of women who experience blood clots out of 10,000 Women Years (WY). The data on pregnancy-related blood clot occurrences is based on the duration of pregnancy found in reference studies, and the chart provides a range for the number of blood clots per 10,000 Women Years during pregnancy.*

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Image-10 (Image 10)

This is a medication called Ethinyl Estradiol Tablets, available in 3mg/0.03mg strength. The text also mentions Drosperinone and Eniny sl Tt in 3mg/0mg strength, which possibly refers to another variant of the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.